The oncofetal H19 RNA connection: Hypoxia, p53 and cancer
Authors:
- Imad J. MatoukIMImad J. Matouk
- Shaul MezanSMShaul Mezan
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1803 (4) , 443-451
Abstract
No abstract availableKeywords
Funding Information
- ISF (LSHB-CT-2004-512034, LSHB-CT-2005-018961, LSHB-CT-2008-223317)
- Barbara Fox Miller
- Lille and Alfy Nathan
- Horowitz
- Wolfson Foundations
This publication has 30 references indexed in Scilit:
- The H19 locus acts in vivo as a tumor suppressorProceedings of the National Academy of Sciences, 2008
- Enhancer Blocking Activity of the Insulator at H19-ICR Is Independent of Chromatin Barrier EstablishmentMolecular and Cellular Biology, 2008
- Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent MannerPLOS ONE, 2008
- The role of hypoxia-inducible factors in tumorigenesisCell Death & Differentiation, 2008
- The H19 Non-Coding RNA Is Essential for Human Tumor GrowthPLOS ONE, 2007
- Epigenetic Alterations of H19 and LIT1 Distinguish Patients with Beckwith-Wiedemann Syndrome with Cancer and Birth DefectsThe American Journal of Human Genetics, 2002
- The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene?Oncogene, 1997
- Epigenetic lesions at the H19 locus in Wilms' tumour patientsNature Genetics, 1994
- Tumour-suppressor activity of H19 RNANature, 1993
- The human ASM (Adult Skeletal Muscle) gene Expression and chromosomal assignment to 11p15Biochemical and Biophysical Research Communications, 1991